[go: up one dir, main page]

DK0703786T3 - Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS - Google Patents

Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS

Info

Publication number
DK0703786T3
DK0703786T3 DK94913518T DK94913518T DK0703786T3 DK 0703786 T3 DK0703786 T3 DK 0703786T3 DK 94913518 T DK94913518 T DK 94913518T DK 94913518 T DK94913518 T DK 94913518T DK 0703786 T3 DK0703786 T3 DK 0703786T3
Authority
DK
Denmark
Prior art keywords
decapeptides
nona
aids
treatment
pct
Prior art date
Application number
DK94913518T
Other languages
English (en)
Inventor
Juergen Engel
Bernhard Kutscher
Michael Bernd
Ulf Niemeyer
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Application granted granted Critical
Publication of DK0703786T3 publication Critical patent/DK0703786T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK94913518T 1993-06-18 1994-04-02 Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS DK0703786T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4320201A DE4320201A1 (de) 1993-06-18 1993-06-18 Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
PCT/EP1994/001037 WO1995000168A1 (de) 1993-06-18 1994-04-02 Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids

Publications (1)

Publication Number Publication Date
DK0703786T3 true DK0703786T3 (da) 2002-05-27

Family

ID=6490614

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94913518T DK0703786T3 (da) 1993-06-18 1994-04-02 Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS

Country Status (24)

Country Link
US (1) US5985834A (da)
EP (1) EP0703786B1 (da)
JP (1) JPH08511784A (da)
KR (1) KR100352541B1 (da)
CN (1) CN1136915C (da)
AT (1) ATE213164T1 (da)
AU (1) AU688315B2 (da)
BR (1) BR9406893A (da)
CZ (1) CZ285997B6 (da)
DE (2) DE4320201A1 (da)
DK (1) DK0703786T3 (da)
ES (1) ES2172533T3 (da)
FI (1) FI113008B (da)
HU (1) HUT73673A (da)
IL (1) IL110045A (da)
NO (1) NO320945B1 (da)
PL (1) PL175580B1 (da)
PT (1) PT703786E (da)
RU (1) RU2154492C2 (da)
SG (1) SG52240A1 (da)
TW (1) TW370532B (da)
UA (1) UA41938C2 (da)
WO (1) WO1995000168A1 (da)
ZA (1) ZA944347B (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5932547A (en) 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
US5981489A (en) * 1996-07-18 1999-11-09 Alza Corporation Non-aqueous protic peptide formulations
US8962558B2 (en) 1997-07-04 2015-02-24 Johannes C. van Groeninghen Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3
DE19728737C1 (de) * 1997-07-04 1999-02-11 Johannes Christian Groeninghen Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten
PL357999A1 (en) * 2000-03-14 2004-08-09 Zentaris Gmbh Lhrh-antagonists, production and use thereof as medicament
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
US20040138138A1 (en) * 2001-08-02 2004-07-15 Jurgen Engel Use of LHRH-antagonists in doses that do not cause castration for the improvement of T-cell mediated immunity
IL147138A0 (en) * 2001-12-17 2002-08-14 Yeda Res & Dev Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
US7250514B1 (en) * 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
KR20050118057A (ko) * 2004-04-24 2005-12-15 김상희 아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
RU2314818C1 (ru) * 2006-03-06 2008-01-20 Институт биоорганической химии РАН им. М.М. Шемякина и Ю.А. Овчинникова (ИБХ) Средство, обладающее ингибирующей способностью по отношению к обратной транскриптазе вируса иммунодефицита человека
CA2726247C (en) * 2008-05-29 2018-06-26 Isr Immune System Regulation Ab Method and means for treating viral disease, in particular hiv/aids
CN102144037A (zh) 2008-07-07 2011-08-03 牛津纳米孔技术有限公司 检测碱基的孔
CN102245760A (zh) 2008-07-07 2011-11-16 牛津纳米孔技术有限公司 酶-孔构建体
GB0820927D0 (en) 2008-11-14 2008-12-24 Isis Innovation Method
US9222082B2 (en) * 2009-01-30 2015-12-29 Oxford Nanopore Technologies Limited Hybridization linkers
WO2010086622A1 (en) 2009-01-30 2010-08-05 Oxford Nanopore Technologies Limited Adaptors for nucleic acid constructs in transmembrane sequencing
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
JP6169976B2 (ja) 2011-02-11 2017-07-26 オックスフォード ナノポール テクノロジーズ リミテッド 変異体細孔
WO2013014451A1 (en) 2011-07-25 2013-01-31 Oxford Nanopore Technologies Limited Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
KR102083695B1 (ko) 2012-04-10 2020-03-02 옥스포드 나노포어 테크놀로지즈 리미티드 돌연변이체 리세닌 기공
WO2014013259A1 (en) 2012-07-19 2014-01-23 Oxford Nanopore Technologies Limited Ssb method
SG11201507138RA (en) 2013-03-08 2015-10-29 Oxford Nanopore Tech Ltd Enzyme stalling method
GB201314695D0 (en) 2013-08-16 2013-10-02 Oxford Nanopore Tech Ltd Method
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
GB201403096D0 (en) 2014-02-21 2014-04-09 Oxford Nanopore Tech Ltd Sample preparation method
WO2015166275A1 (en) 2014-05-02 2015-11-05 Oxford Nanopore Technologies Limited Mutant pores
KR20170042794A (ko) 2014-09-01 2017-04-19 브이아이비 브이지더블유 돌연변이체 csgg 포어
US10266885B2 (en) 2014-10-07 2019-04-23 Oxford Nanopore Technologies Ltd. Mutant pores
GB201418159D0 (en) 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
CN105837674A (zh) * 2016-03-08 2016-08-10 无限极（中国）有限公司 一种东方铃蟾多肽及其制备方法与应用
GB201609220D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
GB201807793D0 (en) 2018-05-14 2018-06-27 Oxford Nanopore Tech Ltd Method

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677193A (en) * 1985-02-22 1987-06-30 The Salk Institute For Biological Studies Peptides containing an aliphatic-aromatic ketone side chain
US5073624A (en) * 1985-04-09 1991-12-17 Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
WO1989009229A1 (en) * 1988-03-31 1989-10-05 Immunobiology Research Institute, Inc. Treatment of hiv viremic patients with thymopentin
WO1990003980A1 (en) * 1988-10-14 1990-04-19 Administrators Of The Tulane Educational Fund Therapeutic peptides
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids
US5087625A (en) * 1990-10-19 1992-02-11 Boehringer Ingelheim Pharmaceuticals, Inc. Pyridodiazepines and their use in the prevention or treatment of HIV infection
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists
ATE164167T1 (de) * 1990-12-21 1998-04-15 Curative Tech Inc Angiogene peptide
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.

Also Published As

Publication number Publication date
ATE213164T1 (de) 2002-02-15
DE4320201A1 (de) 1995-01-12
TW370532B (en) 1999-09-21
SG52240A1 (en) 1998-09-28
PL175580B1 (pl) 1999-01-29
IL110045A (en) 2000-06-01
JPH08511784A (ja) 1996-12-10
UA41938C2 (uk) 2001-10-15
RU2154492C2 (ru) 2000-08-20
EP0703786B1 (de) 2002-02-13
AU6564794A (en) 1995-01-17
CN1125400A (zh) 1996-06-26
ES2172533T3 (es) 2002-10-01
EP0703786A1 (de) 1996-04-03
KR100352541B1 (ko) 2002-12-26
CZ285997B6 (cs) 1999-12-15
US5985834A (en) 1999-11-16
PL312219A1 (en) 1996-04-01
KR960703015A (ko) 1996-06-19
HUT73673A (en) 1996-09-30
DE59410052D1 (de) 2002-03-21
BR9406893A (pt) 1996-09-10
CN1136915C (zh) 2004-02-04
NO954996D0 (no) 1995-12-08
ZA944347B (en) 1995-02-15
IL110045A0 (en) 1994-10-07
FI956014A0 (fi) 1995-12-14
WO1995000168A1 (de) 1995-01-05
PT703786E (pt) 2002-07-31
AU688315B2 (en) 1998-03-12
HU9503605D0 (en) 1996-02-28
FI113008B (fi) 2004-02-27
NO320945B1 (no) 2006-02-20
FI956014L (fi) 1995-12-14
NO954996L (no) 1995-12-08
CZ308995A3 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
MY125978A (en) Admantane derivatives
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
MXPA04001912A (es) Aminobenzofenonas novedosas.
DK0787135T3 (da) Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
AU2811400A (en) Stable formulation containing fumagillin
MXPA05011249A (es) Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol.
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
MXPA03000959A (es) Asociaciones dalfopristina/quinupristina con cefpiroma.
WO2000067733A3 (de) Medikament zur therapie der männlichen infertilität
UA32315A (uk) Спосіб накладання шкірного шва
UA32580C2 (uk) Засіб для лікування паралітичної непрохідності кишечнику
UA35854A (uk) Спосіб лікування приховано протікаючого силікотуберкульозу
UA32280A (uk) Спосіб формування тонко-товстокишкового анастомозу бік у бік
CA2162468A1 (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids